| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Sanjiv A Luther | Q51797070 |
| P2093 | author name string | Cyster JG | |
| P2860 | cites work | Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3 | Q24307852 |
| The C5a chemoattractant receptor mediates mucosal defence to infection | Q24318486 | ||
| Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells | Q24563114 | ||
| Delayed wound healing in CXCR2 knockout mice | Q24647498 | ||
| The MCP/eotaxin subfamily of CC chemokines | Q28137923 | ||
| A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo | Q28140312 | ||
| A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
| Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors | Q28235818 | ||
| Interleukin-13: central mediator of allergic asthma | Q28291712 | ||
| Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice | Q28509805 | ||
| The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation | Q28584806 | ||
| Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 | ||
| Control of inflammation, cytokine expression, and germinal center formation by BCL-6 | Q28585541 | ||
| CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis | Q28587371 | ||
| CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c | Q28588634 | ||
| Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. | Q28590391 | ||
| Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 | Q28591681 | ||
| CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection | Q28594148 | ||
| Interleukin-10-deficient mice develop chronic enterocolitis | Q29547881 | ||
| Mast cell-T cell interactions | Q33731155 | ||
| Chemokines and cell migration in secondary lymphoid organs | Q33807114 | ||
| Modulating chemokines: more lessons from viruses | Q33826596 | ||
| Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. | Q33897342 | ||
| Chemokines in tissue-specific and microenvironment-specific lymphocyte homing | Q33898971 | ||
| Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis | Q33902443 | ||
| Signaling and transcription in T helper development | Q33932729 | ||
| The role of chemokine receptors in primary, effector, and memory immune responses | Q33932742 | ||
| Dendritic cell regulation of TH1-TH2 development | Q34023428 | ||
| The instructive role of innate immunity in the acquired immune response | Q34375203 | ||
| Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression | Q35133507 | ||
| Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells | Q35532427 | ||
| Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses | Q35786914 | ||
| Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse | Q35822641 | ||
| The role of macrophage inflammatory protein 1 alpha in Schistosoma mansoni egg-induced granulomatous inflammation | Q36361834 | ||
| Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. | Q36367109 | ||
| Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. | Q36368947 | ||
| Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor | Q36380911 | ||
| Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways | Q36381040 | ||
| Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice | Q36400287 | ||
| Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines | Q36400419 | ||
| HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. | Q36401498 | ||
| Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses | Q36404327 | ||
| Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection | Q37303301 | ||
| MCP-1 protects mice in lethal endotoxemia | Q37368530 | ||
| The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells | Q40831645 | ||
| Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop | Q40875349 | ||
| Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells | Q40887705 | ||
| Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes | Q41054119 | ||
| Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells | Q41648813 | ||
| The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells | Q41687602 | ||
| Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s | Q42115088 | ||
| Selective suppression of IL-12 production by chemoattractants | Q44963436 | ||
| Pertussis infection and vaccination induces Th1 cells | Q45272435 | ||
| T-cell subsets: chemokine receptors guide the way. | Q46027701 | ||
| Chemokine receptors: keys to AIDS pathogenesis? | Q47964346 | ||
| Requirement of MIP-1 alpha for an inflammatory response to viral infection. | Q52509286 | ||
| A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. | Q52541798 | ||
| Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. | Q53463453 | ||
| Distinct patterns and kinetics of chemokine production regulate dendritic cell function. | Q54093362 | ||
| CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells | Q56880736 | ||
| Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site | Q56943333 | ||
| Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 | Q59089322 | ||
| CCR5 is characteristic of Th1 lymphocytes | Q59092711 | ||
| Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys | Q59713916 | ||
| Macrophage-derived chemokine production by activated human T cellsin vitro andin vivo: preferential association with the production of type 2 cytokines | Q61638220 | ||
| Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen | Q71000507 | ||
| Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential | Q71011981 | ||
| Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells | Q73035410 | ||
| Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12 | Q73086212 | ||
| Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo | Q73336913 | ||
| MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation | Q73867325 | ||
| Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the inte | Q73869118 | ||
| Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4 | Q73910646 | ||
| Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent | Q74165253 | ||
| The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection | Q74183183 | ||
| BCL-6 regulates chemokine gene transcription in macrophages | Q74268408 | ||
| Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine | Q74527777 | ||
| Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation | Q77353738 | ||
| IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts | Q77492715 | ||
| Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses | Q77723690 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell differentiation | Q210861 |
| P304 | page(s) | 102-107 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | Chemokines as regulators of T cell differentiation | |
| P478 | volume | 2 |
| Q42293325 | A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients |
| Q44323461 | A chemokine, SDF-1, reduces the effectiveness of multiple axonal repellents and is required for normal axon pathfinding. |
| Q33293538 | A decline in CCL3-5 chemokine gene expression during primary simian-human immunodeficiency virus infection |
| Q40446931 | A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: Utilization of U937 monocytic cells. |
| Q42695490 | A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system |
| Q37707714 | Activation of the cholinergic anti-inflammatory system by nicotine attenuates arthritis via suppression of macrophage migration |
| Q35131239 | Adaptive and innate immune responses to gene transfer vectors: role of cytokines and chemokines in vector function |
| Q39377291 | Altered expression of CXCR3 and CCR6 and their ligands in HTLV-1 carriers and HAM/TSP patients |
| Q35091425 | Alveolar macrophages infected with Ames or Sterne strain of Bacillus anthracis elicit differential molecular expression patterns |
| Q24802958 | An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema |
| Q44497452 | Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice |
| Q37495165 | Antigen-specific gene expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets |
| Q37130767 | Are plasma mineral levels related to antibody response to influenza vaccination in older adults? |
| Q99711514 | Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression |
| Q36444611 | Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population |
| Q46171858 | Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. |
| Q40195502 | Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis |
| Q33584997 | Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival |
| Q36684961 | Avidity of human T cell receptor engineered CD4(+) T cells drives T-helper differentiation fate |
| Q28204573 | B cells and professional APCs recruit regulatory T cells via CCL4 |
| Q52364066 | Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation. |
| Q79715637 | Blocking the CC chemokine receptor 5 pathway by antisense peptide nucleic acid prolongs islet allograft survival |
| Q37156409 | Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses |
| Q33558186 | Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2. |
| Q39711144 | CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes |
| Q35116129 | CCL27/PESKY: a novel paradigm for chemokine function |
| Q43955957 | CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms |
| Q19028101 | CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals |
| Q61905788 | CCL4L Polymorphisms and CCL4/CCL4L Serum Levels Are Associated with Psoriasis Severity |
| Q37710085 | CCL5 as an adjuvant for cancer immunotherapy |
| Q33359789 | CCL5 regulation of mucosal chlamydial immunity and infection |
| Q35717991 | CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes |
| Q41435122 | CCL8 and the Immune Control of Cytomegalovirus in Organ Transplant Recipients |
| Q36384883 | CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation |
| Q48142373 | CCR2 Regulates the Immune Response by Modulating the Interconversion and Function of Effector and Regulatory T Cells |
| Q35848441 | CCR2 is required for CD8-induced graft-versus-host disease. |
| Q37045180 | CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection. |
| Q38702121 | CCR5 blockade for neuroinflammatory diseases--beyond control of HIV. |
| Q81242894 | CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice |
| Q34118698 | CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation |
| Q33584223 | CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease |
| Q44143839 | CCR5 mediates pro-osteoclastic and osteoclastogenic leukocyte chemoattraction. |
| Q36228080 | CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence |
| Q61448769 | CCR7 Is Recruited to the Immunological Synapse, Acts as Co-stimulatory Molecule and Drives LFA-1 Clustering for Efficient T Cell Adhesion Through ZAP70 |
| Q40982180 | CCR7 and CXCR4 Expression in Primary Head and Neck Squamous Cell Carcinomas and Nodal Metastases – a Clinical and Immunohistochemical Study |
| Q36667984 | CD22 is required for protection against West Nile virus Infection |
| Q40152588 | CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions |
| Q41091257 | CD8+ Effector T Cell Migration to Pancreatic Islet Grafts Is Dependent on Cognate Antigen Presentation by Donor Graft Cells |
| Q47603368 | CK12a, a CCL19-like Chemokine That Orchestrates both Nasal and Systemic Antiviral Immune Responses in Rainbow Trout |
| Q26992010 | CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems |
| Q40478682 | CXCL12 signaling is independent of Jak2 and Jak3. |
| Q44572411 | CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection |
| Q40526667 | CXCR4-mediated suppressor of cytokine signaling up-regulation inactivates growth hormone function. |
| Q52959842 | Cancer immunotherapy: dendritic-cell vaccines on the move. |
| Q46251748 | Carrion's Disease: the Sound of Silence. |
| Q38098176 | Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. |
| Q38260032 | Characterisation of inflammatory processes in Helicobacter pylori-induced gastric lymphomagenesis in a mouse model |
| Q37072376 | Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis |
| Q35550834 | Chemokine receptor 5 is dispensable for innate and adaptive immune responses to Listeria monocytogenes infection |
| Q35237638 | Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease |
| Q34754683 | Chemokine receptor antagonism as an approach to anti-inflammatory therapy: 'just right' or plain wrong? |
| Q47711199 | Chemokine receptors in T-cell-mediated diseases of the skin |
| Q60931267 | Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization |
| Q44415928 | Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus |
| Q34798754 | Chemokines and cancer. |
| Q34725964 | Chemokines and leucocyte migration in parasitic disease |
| Q36560836 | Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction |
| Q35668771 | Chemokines and their receptors play important roles in the development of hepatocellular carcinoma |
| Q37256207 | Chemokines and transplant vasculopathy |
| Q33792344 | Chemokines as Cancer Vaccine Adjuvants. |
| Q26778684 | Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring |
| Q34119204 | Chemokines in cancer |
| Q34635703 | Chemokines in health and disease |
| Q35553416 | Chemokines in joint disease: the key to inflammation? |
| Q35216944 | Chemokines in the systemic organization of immunity |
| Q90114718 | Chronic Inflammation Directs an Olfactory Stem Cell Functional Switch from Neuroregeneration to Immune Defense |
| Q64244484 | Cold Tumors: A Therapeutic Challenge for Immunotherapy |
| Q42944784 | Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. |
| Q33685627 | Comprehensive assessment of chemokine expression profiles by flow cytometry |
| Q33321029 | Confocal immunolocalization of VE-cadherin- and CXC chemokine-expressing endothelial cells in periapical granulomas |
| Q37686172 | Coordinated post-transcriptional regulation of the chemokine system: messages from CCL2 |
| Q36661617 | Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury |
| Q35027542 | Cytokine and chemokine responses underlying acute and chronic Trichuris muris infection |
| Q34700403 | Cytokine memory of T helper lymphocytes |
| Q36857976 | Decoding the chemokine network that links leukocytes with decidual cells and the trophoblast during early implantation. |
| Q33622444 | Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide. |
| Q40307026 | Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors |
| Q46988651 | Deorphanization of Dresden G protein-coupled receptor for an odorant receptor |
| Q97588865 | Development and characterization of novel mouse monoclonal antibodies against chicken chemokine CC motif ligand 4 |
| Q37417702 | Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study |
| Q37003960 | Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection |
| Q46023372 | Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. |
| Q52559477 | Disruption of CD40-CD40 ligand pathway inhibits the development of intestinal muscle hypercontractility and protective immunity in nematode infection. |
| Q53455335 | Distinct functional capacities of mouse thymic and splenic dendritic cell populations. |
| Q40774919 | Distinct mRNA microarray profiles of tolerogenic dendritic cells |
| Q52014611 | Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. |
| Q92134662 | Down regulation of RANTES in pleural site is associated with inhibition of antigen specific response in tuberculosis |
| Q34221754 | Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin |
| Q40208549 | Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation |
| Q27309182 | Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5. |
| Q36179686 | Emerging drugs in psoriasis |
| Q89410987 | Emerging pathways of communication between the heart and non-cardiac organs |
| Q34202054 | Endocrine self and gut non-self intersect in the pancreatic lymph nodes |
| Q56897802 | Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccination |
| Q38988311 | Enhanced LPS-induced peritonitis in mice deficiency of cullin 4B in macrophages |
| Q40464370 | Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12. |
| Q55263314 | Enhancement of Immunoregulatory Function of Modified Bone Marrow Mesenchymal Stem Cells by Targeting SOCS1. |
| Q92856694 | Entanglement of CCR5 and Alzheimer's Disease |
| Q82349154 | Evaluation of serum levels of chemokines during interferon-β treatment in multiple sclerosis patients: a 1-year, observational cohort study |
| Q36715205 | Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy |
| Q37924625 | Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells |
| Q42445930 | Expression of CS-1 fibronectin precedes monocyte chemoattractant protein-1 production during elicitation of allergic contact dermatitis. |
| Q39758876 | Expression of CXCR6 on CD8(+) T cells was up-regulated in allograft rejection |
| Q85197747 | Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma |
| Q34617035 | Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma |
| Q40753414 | Extracellular mRNA induces dendritic cell activation by stimulating tumor necrosis factor-alpha secretion and signaling through a nucleotide receptor |
| Q36370854 | Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation |
| Q54247821 | Gene expression analysis for pneumonia caused by Gram-positive bacterial infection. |
| Q35170006 | Gene expression analysis of dendritic cells that prevent diabetes in NOD mice: analysis of chemokines and costimulatory molecules |
| Q35946889 | Gene expression changes in peripheral blood mononuclear cells during measles virus infection |
| Q37144567 | Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis |
| Q45299615 | Gene expression profiles of peripheral and cord blood mononuclear cells altered by thymic stromal lymphopoietin |
| Q57074004 | Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs |
| Q27346600 | Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma |
| Q54471126 | Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. |
| Q46026383 | Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer. |
| Q37020098 | Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii |
| Q85039493 | Helicobacter heilmannii can induce gastric lymphoid follicles in mice via a Peyer's patch-independent pathway |
| Q28260051 | Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice |
| Q37153906 | Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis |
| Q80319155 | Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a |
| Q44493296 | Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration |
| Q37284993 | Human trophoblast cells induced MDSCs from peripheral blood CD14(+) myelomonocytic cells via elevated levels of CCL2 |
| Q40700858 | IRF3 mediates a TLR3/TLR4-specific antiviral gene program |
| Q35845313 | Identifying chemokines as therapeutic targets in renal disease: lessons from antagonist studies and knockout mice. |
| Q34398643 | Immune function of astrocytes |
| Q91973227 | Immunity to Influenza is dependent on MHC II polymorphism: study with 2 HLA transgenic strains |
| Q26860507 | Immunologic regulation in pregnancy: from mechanism to therapeutic strategy for immunomodulation |
| Q48355113 | Immunological characterization of the early human fracture hematoma |
| Q42203345 | Immunological profile of periapical endodontic infections from HIV- and HIV+ patients. |
| Q84439284 | Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets |
| Q33853856 | Immunosuppressive and angiogenic cytokine profile associated with Bartonella bacilliformis infection in post-outbreak and endemic areas of Carrion's disease in Peru |
| Q35165095 | Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis |
| Q44203897 | Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression |
| Q35149267 | Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation |
| Q51711787 | Increased expression of CCL4/MIP-1β in CD8+ cells and CD4+ cells in sarcoidosis. |
| Q40034111 | Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases |
| Q38156767 | Initial immunopathogenesis of multiple sclerosis: innate immune response. |
| Q39988425 | Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis |
| Q35125561 | Insights into the Staphylococcus aureus-host interface: global changes in host and pathogen gene expression in a rabbit skin infection model |
| Q48429473 | Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages |
| Q40700509 | Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells |
| Q47776275 | Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance |
| Q43922049 | Intravital two-photon microscopy of host-pathogen interactions in a mouse model of Staphylococcus aureus skin abscess formation |
| Q42522139 | Involvement of CC chemokines in gammadelta T lymphocyte trafficking during allergic inflammation: the role of CCL2/CCR2 pathway |
| Q24801279 | Involvement of beta-chemokines in the development of inflammatory demyelination |
| Q33714927 | Kif4A mediate the accumulation and reeducation of THP-1 derived macrophages via regulation of CCL2-CCR2 expression in crosstalking with OSCC |
| Q34572115 | Knockout mice: a paradigm shift in modern immunology |
| Q52584627 | LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus. |
| Q73443947 | Lack of association of CCR2-64I and CCR5-Delta 32 with type 1 diabetes and latent autoimmune diabetes in adults |
| Q47759757 | Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease |
| Q33284841 | Laser capture microdissection and cDNA array analysis of endometrium identify CCL16 and CCL21 as epithelial-derived inflammatory mediators associated with endometriosis |
| Q30479618 | Leukocyte migration and graft-versus-host disease |
| Q35139945 | Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection |
| Q33862928 | Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling |
| Q34139610 | Lymphocyte traffic control by chemokines |
| Q37267001 | Lymphocytic choriomeningitis virus-induced central nervous system disease: a model for studying the role of chemokines in regulating the acute antiviral CD8+ T-cell response in an immune-privileged organ |
| Q54562424 | MCP-1/CCR2 signalling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production. |
| Q36084912 | Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial |
| Q48831588 | Maternal hematopoietic TNF, via milk chemokines, programs hippocampal development and memory |
| Q39126530 | Mechanisms of Regulation of the Chemokine-Receptor Network. |
| Q26753106 | Mechanisms of T cell organotropism |
| Q37620006 | Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid |
| Q36307846 | MicroRNA expression profiles in human CD3+ T cells following stimulation with anti-human CD3 antibodies |
| Q35145798 | Migration and T-lymphocyte effector function |
| Q33825688 | Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles |
| Q41616829 | Molecular Evaluation of the IFN γ +874, TNF α -308, and IL-1Ra VNTR Sequences in Silicosis. |
| Q46865455 | Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice |
| Q38956732 | Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia |
| Q46151212 | Monocyte chemotactic protein-1 level in the aqueous humour as a prognostic factor for the outcome of trabeculectomy |
| Q29622852 | Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 |
| Q73047117 | Monocyte-derived RANTES is intrinsically elevated in periodontal disease while MCP-1 levels are related to inflammation and are inversely correlated with IL-12 levels |
| Q92538377 | More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis |
| Q34009652 | Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response |
| Q36634172 | Multiple roles for chemokines in the pathogenesis of SIV infection |
| Q92921962 | Neonatal T Follicular Helper Cells Are Lodged in a Pre-T Follicular Helper Stage Favoring Innate Over Adaptive Germinal Center Responses |
| Q36823525 | New approaches in the treatment of HIV/AIDS - focus on maraviroc and other CCR5 antagonists |
| Q36160526 | Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints |
| Q42283940 | Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity. |
| Q35807532 | Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells |
| Q54786994 | Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. |
| Q35064033 | Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection |
| Q73061736 | Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle |
| Q38949809 | Pertussis leukocytosis: mechanisms, clinical relevance and treatment |
| Q52548644 | Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. |
| Q90211749 | Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients |
| Q36370294 | Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes |
| Q37524290 | Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection |
| Q35795429 | Postoperative Changes in Aqueous Monocyte Chemotactic Protein-1 Levels and Bleb Morphology after Trabeculectomy vs. Ex-PRESS Shunt Surgery |
| Q47437476 | Prediction of Host-Pathogen Interactions for Helicobacter pylori by Interface Mimicry and Implications to Gastric Cancer |
| Q36835605 | Proteomic dissection of LPS-inducible, PHF8-dependent secretome reveals novel roles of PHF8 in TLR4-induced acute inflammation and T cell proliferation |
| Q51240508 | Pulmonary persistence of graphene nanoplatelets may disturb physiological and immunological homeostasis. |
| Q36223307 | Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection |
| Q45977569 | Reciprocal chemokine receptor and ligand expression in the human placenta: implications for cytotrophoblast differentiation. |
| Q36403789 | Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis |
| Q46434837 | Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cells |
| Q33444699 | Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG. |
| Q39621271 | Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2. |
| Q47969482 | Regulation of CCR5 expression and MIP-1α production in CD4+ T cells from patients with rheumatoid arthritis |
| Q37204048 | Regulation of G-protein-coupled signaling pathways in allergic inflammation |
| Q37726377 | Regulation of immune function by G protein-coupled receptors, trimeric G proteins, and RGS proteins. |
| Q35186648 | Regulators of G protein signalling: potential targets for treatment of allergic inflammatory diseases such as asthma |
| Q89959177 | Research Note: Correlation analysis of interleukin-6, interleukin-8, and C-C motif chemokine ligand 2 gene expression in chicken spleen and cecal tissues after Eimeria tenella infection in vivo |
| Q36494119 | Robustness trade-offs and host-microbial symbiosis in the immune system |
| Q34572155 | Role of chemokines in the pathogenesis of asthma |
| Q40572452 | Role of keratinocytes in antigen presentation and polarization of human T lymphocytes |
| Q24794146 | Science review: role of coagulation protease cascades in sepsis |
| Q79361616 | Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection |
| Q40650914 | Simian/Human Immunodeficiency Virus89.6Expressing the Chemokine Genes MIP-1α, RANTES, or Lymphotactin |
| Q40134491 | Single CX3CL1-Ig DNA administration enhances T cell priming in vivo |
| Q43494866 | Stromal cell derived factor 1 synthesis by spleen cells in rodent malaria, and the effects of in vivo supplementation of SDF-1alpha and CXCR4 receptor blocker |
| Q24292437 | Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions |
| Q40696990 | Structure, chromosomal localization and expression of the mouse regulator of G-protein signaling10 gene (mRGS10). |
| Q41027313 | Subpopulations of M-MDSCs from mice infected by an immunodeficiency-causing retrovirus and their differential suppression of T- vs B-cell responses |
| Q50896849 | Systems level analysis of osteoclastogenesis reveals intrinsic and extrinsic regulatory interactions. |
| Q34612549 | T helper cell differentiation: on again, off again |
| Q37214782 | TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae |
| Q36844950 | Targeting costimulatory pathways for tumor immunotherapy |
| Q35056023 | Targeting monocyte chemoattractant protein-1 signalling in disease |
| Q26765184 | Targeting the CCL2-CCR2 signaling axis in cancer metastasis |
| Q41267932 | Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum |
| Q35769460 | Th2 cells: orchestrating barrier immunity |
| Q37346633 | The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity |
| Q35132169 | The Chemokine, CCL3, and Its Receptor, CCR1, Mediate Thoracic Radiation–Induced Pulmonary Fibrosis |
| Q35769489 | The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis |
| Q35568430 | The Role of Chemokines in Inflammatory Skin Diseases |
| Q36317414 | The abnormal expression of CCR4 and CCR6 on Tregs in rheumatoid arthritis |
| Q35036907 | The absence of CCR7 results in dysregulated monocyte migration and immunosuppression facilitating chronic cutaneous leishmaniasis |
| Q36097099 | The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant |
| Q79450264 | The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties |
| Q43910951 | The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. |
| Q36216100 | The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis |
| Q40639914 | The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. |
| Q34929196 | The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses. |
| Q37145450 | The cholesterol-binding antibiotic nystatin induces expression of macrophage inflammatory protein-1 in macrophages |
| Q34862240 | The immunological synapse: integrins take the stage. |
| Q35686001 | The influence of follicular migration on T-cell differentiation |
| Q33769457 | The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. |
| Q44694227 | The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii |
| Q34330215 | The rat cytomegalovirus R33-encoded G protein-coupled receptor signals in a constitutive fashion |
| Q35031901 | The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). |
| Q38747937 | The role of chemokines in hypertension and consequent target organ damage |
| Q35583253 | The role of cytokines and chemokines in Histoplasma capsulatum infection |
| Q36389337 | Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines |
| Q35183162 | Three or more routes for leukocyte migration into the central nervous system |
| Q38081181 | Tolerance induction at the early maternal-placental interface through selective cell recruitment and targeting by immune polypeptides |
| Q34438782 | Tolerogenic dendritic cells that inhibit autoimmune arthritis can be induced by a combination of carvacrol and thermal stress |
| Q34489931 | Trafficking from the bone marrow to the thymus: a prerequisite for thymopoiesis |
| Q90632399 | Transcriptional Profiles Associated with Marek's Disease Virus in Bursa and Spleen Lymphocytes Reveal Contrasting Immune Responses during Early Cytolytic Infection |
| Q36607168 | Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infection |
| Q37728659 | Type 1 T-cell responses in chlamydial lung infections are associated with local MIP-1alpha response. |
| Q35695840 | Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF. |
| Q34491623 | Understanding selective trafficking of lymphocyte subsets |
| Q42947524 | Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells |
| Q35812229 | Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB |
| Q37242997 | Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells. |
| Q40715506 | YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T-cell proliferation through inactivation of the phosphatidylinositol 3-kinase pathway |
| Q35963596 | mRNA expression in different developmental stages of the chicken bursa of Fabricius |
| Q33964713 | γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis |
Search more.